12399456https://www.upal.com.my/zh/feeds/jobFeedKwongwahArray ( [0] => HTTP/1.1 200 OK [1] => Date: Sat, 24 May 2025 09:47:59 GMT [2] => Content-Type: text/xml; charset=utf-8 [3] => Connection: close [4] => Nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800} [5] => Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=%2BpeN65WP19cgAa2JbdE5wGdruPTiI6IQVYDJOPUnsqkNHrzxMoD9jk3R1%2B1g1VU%2B3oBfbO3xVsBFSESJXX8s4EpAGIMCeEfL2eJkNBol02bjJyJpfMazOkp5J1QxP88JOCE%3D"}],"group":"cf-nel","max_age":604800} [6] => Server: cloudflare [7] => Vary: Accept-Encoding [8] => X-Powered-By: PHP/7.4.33 [9] => Cache-Control: no-cache, private [10] => Cf-Ray: 944bdfee3f576e6b-KUL [11] => X-Frame-Options: SAMEORIGIN [12] => X-Xss-Protection: 1; mode=block [13] => X-Content-Type-Options: nosniff [14] => Referrer-Policy: no-referrer-when-downgrade [15] => Cf-Cache-Status: DYNAMIC [16] => Set-Cookie: UpalLiveSession=eyJpdiI6IlwvSENsN2REb2ZDbDlDeHlaQmkxN1VRPT0iLCJ2YWx1ZSI6ImMzRkdxemdBcEo0T2xVVFFrdzVuK2Y1SzdhaWFKeE9RMklOaHFjQ2VRcitHdHZ5RGpuS1E1V0d6aCtLVjIwZHFUaEc5WFYrUlwveVgrT1NqYW84UllaUT09IiwibWFjIjoiZjE5MzVmYTBkZmMxMzdhOWFiZDI1OTA2MDA4NGViNTkwNGRmOGJkZDAyMzY2ZjI0ZDVmNjM2NzgzMGJkNDg4ZCJ9; HttpOnly; Path=/; Max-Age=94608000; Expires=Tue, 23 May 2028 09:40:47 GMT [17] => alt-svc: h3=":443"; ma=86400 [18] => server-timing: cfL4;desc="?proto=TCP&rtt=1027&min_rtt=1009&rtt_var=317&sent=4&recv=6&lost=0&retrans=0&sent_bytes=3000&recv_bytes=756&delivery_rate=2870168&cwnd=252&unsent_bytes=0&cid=db4451293979f1c9&ts=19&x=0" ) 789

由中国广东省内专家研制、针对新冠肺炎的中成药“肺炎一号”，于周四正式委托药厂量产，药厂预料下周可以陆续出货，供应予省内各医院使用。但该款新药属于医院制剂，根据规定，它只能在已申报的医院内部使用，一般市民暂时无法购买。

据当地媒体报道，该款新药由5味药材制成，配方并未公开，在周二已获得省药品监督管理局优先审批通过，由广东一方制药有限公司生产。按目前公布的资料，该药有效期为半年，仅对轻症患者有治疗功效，并无预防作用，非确诊者毋须服用。，

省药品监管局早前曾进行临床试验，供广州市第八人民医院的50名轻症患者临床服用该款新药，结果50%患者的咳嗽症状消失、52.4%的咽痛症状消失、69.6%的乏力症状消失，整体症状明显好转，具较好的临床价值。

---

// // // //